Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTracsis Regulatory News (TRCS)

Share Price Information for Tracsis (TRCS)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -5.00 (-1.52%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £96.78m
TRCS Live PriceLast checked at - London Stock Exchange

Intraday Tracsis Share Chart

Director/PDMR Shareholding

17 Jul 2014 07:54

RNS Number : 5781M
Tracsis PLC
17 July 2014
 



 

Tracsis plc

 

("Tracsis" or the "Company")

 

Directors Dealing - Exercise of Options

 

Tracsis announces that it received on 16 July 2014, notice of exercise of options from the following Directors:

 

John McArthur, Chief Executive Officer, exercised 140,000 options at an exercise price of 52p per share from a share option agreement dated 2009. No shares were sold in order to satisfy exercise costs. As a result of this, Mr McArthur's interests in the company increased to 1,112,474 representing 4.2% of the total voting rights of the Company.

 

Max Cawthra, Finance Director, exercised 75,000 options at an exercise price of 49.5p per share from a share option agreement dated 2011. In order to satisfy exercise costs 25,000 shares were subsequently disposed at a price of £3.11. As a result of this transaction, Mr Cawthra's interests in the company increased from 4,000 to 54,000 representing 0.2% of the total voting rights of the Company.

 

Charles Winward, a Non-Executive Director exercised 87,517 options at an exercise price of 40p per share from a share option agreement dated 2007. In order to satisfy exercise costs, income tax, national insurance and other liabilities arising 57,246 shares were subsequently disposed at a price of £3.11. As a result of this transaction Mr Winward's interests in the company will increase from 56,500 to 86,771 representing 0.3% of the total voting rights of the Company.

 

A summary of these transactions and resulting Directors' holdings in Tracsis is as follows:

 

Share holding prior to exercise

Option holding prior to exercise

Options exercised today

Shares sold today

Resulting Share

Holding

% of issued share capital

Non-Executive Directors

Chris Cole (Chair)

-

-

-

-

-

-

Sean Lippell

-

50,000

-

-

-

-

John Nelson

230,824

25,000

-

-

230,824

0.9%

Charles Winward

56,500

137,517

87,517

(57,246)

86,771

0.3%

Executive Directors

Max Cawthra

4,000

235,162

75,000

(25,000)

54,000

0.2%

John McArthur

972,474

240,000

140,000

-

1,112,474

4.2%

Total Interest

1,263,798

687,679

302,517

(82,246)

1,484,069

5.6%

 

 

Accordingly, the Company has today issued 302,517 ordinary shares in the Company "new ordinary shares". Application has been made for the new ordinary shares to be admitted to trading on AIM and dealings are expected to commence on 22 July 2014.

 

Following the issue of the new shares, the number of Ordinary Shares in issue will increase to 26,258,114. For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following this allotment consists of 26,258,114 Shares with voting rights attached (one vote per Share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Tracsis under the DTRs.

 

 

For more information please contact:

 

John McArthur/Max Cawthra, Tracsis plc

 

Tel: 0845 125 9162

Katy Mitchell, WH Ireland Limited

Tel: 0161 832 2174

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMGMNVNFGDZG
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
8th May 202612:22 pmRNSHolding(s) in Company
7th May 20263:45 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSInterim Results
2nd Apr 20267:04 amRNSAcquisition
1st Apr 20267:00 amRNSTotal Voting Rights
27th Mar 20267:00 amRNSNotice of Results and Presentations
26th Mar 20264:51 pmRNSHolding(s) in Company
2nd Mar 20267:00 amRNSBlock Listing Six Monthly Return
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20264:01 pmRNSHolding(s) in Company
25th Feb 20267:00 amRNSTrading Update and North American Contract Win
2nd Feb 20264:03 pmRNSHolding(s) in Company
2nd Feb 20267:00 amRNSTotal Voting Rights
14th Jan 20264:31 pmRNSResult of AGM
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
5th Dec 20257:00 amRNSAnnual Report and Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
21st Nov 20254:45 pmRNSHolding(s) in Company
20th Nov 20257:00 amRNSFinal Results
18th Nov 20254:34 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSTotal Voting Rights
12th Sep 20253:16 pmRNSHolding(s) in Company
1st Sep 202511:30 amRNSBlock Listing Six Monthly Return
1st Sep 202511:28 amRNSTotal Voting Rights
27th Aug 20257:00 amRNSTrading Update and Notice of Results
1st Aug 20257:00 amRNSTotal Voting Rights
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:56 amRNSTransaction in Own Shares
16th Jul 20254:12 pmRNSHolding(s) in Company
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:01 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSBoard Change
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:01 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.